Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Conditions

• Breast Cancer

Interventions

• DRUG: pegylated liposomal doxorubicin hydrochloride
• GENETIC: DNA methylation analysis
• GENETIC: TdT-mediated dUTP nick end labeling assay
• GENETIC: fluorescence in situ hybridization
• GENETIC: loss of heterozygosity analysis
• GENETIC: polymerase chain reaction
• OTHER: immunoenzyme technique
• OTHER: immunohistochemistry staining method
• OTHER: laboratory biomarker analysis
• PROCEDURE: breast duct lavage
• PROCEDURE: neoadjuvant therapy
• PROCEDURE: therapeutic conventional surgery

Sponsor

Dr. Susan Love Research Foundation